176 related articles for article (PubMed ID: 17707275)
1. Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation.
Lopez CA; Feng FY; Herman JM; Nyati MK; Lawrence TS; Ljungman M
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):214-20. PubMed ID: 17707275
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
[TBL] [Abstract][Full Text] [Related]
3. P53-independent apoptosis: a mechanism of radiation-induced cell death of glioblastoma cells.
Haas-Kogan DA; Dazin P; Hu L; Deen DF; Israel A
Cancer J Sci Am; 1996; 2(2):114-21. PubMed ID: 9166509
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition.
Flatmark K; Nome RV; Folkvord S; Bratland A; Rasmussen H; Ellefsen MS; Fodstad Ø; Ree AH
Radiat Oncol; 2006 Aug; 1():25. PubMed ID: 16887021
[TBL] [Abstract][Full Text] [Related]
5. HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway.
Wang CC; Liao YP; Mischel PS; Iwamoto KS; Cacalano NA; McBride WH
Cancer Res; 2006 Jul; 66(13):6756-62. PubMed ID: 16818651
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
Chung YL; Lee MY; Pui NN
Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
[TBL] [Abstract][Full Text] [Related]
7. HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells.
Jin H; Liang L; Liu L; Deng W; Liu J
J Cell Biochem; 2013 Jul; 114(7):1498-509. PubMed ID: 23297003
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate.
Svechnikova I; Gray SG; Kundrotiene J; Ponthan F; Kogner P; Ekström TJ
Int J Oncol; 2003 Mar; 22(3):579-88. PubMed ID: 12579311
[TBL] [Abstract][Full Text] [Related]
9. A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.
De Schutter H; Kimpe M; Isebaert S; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):904-12. PubMed ID: 19215824
[TBL] [Abstract][Full Text] [Related]
10. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
11. [Functional restoration of tumor suppressor p53 alters susceptibility of glioblastoma cells to irradiation--analysis using a cell line containing a temperature-sensitive mutant].
Tsuchiya K
Hokkaido Igaku Zasshi; 2000 Jul; 75(4):265-74. PubMed ID: 10976406
[TBL] [Abstract][Full Text] [Related]
12. The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines.
Chang YL; Huang LC; Chen YC; Wang YW; Hueng DY; Huang SM
Int J Biochem Cell Biol; 2017 Nov; 92():155-163. PubMed ID: 29017950
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity.
McIlwrath AJ; Vasey PA; Ross GM; Brown R
Cancer Res; 1994 Jul; 54(14):3718-22. PubMed ID: 8033090
[TBL] [Abstract][Full Text] [Related]
14. Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells.
Li XN; Parikh S; Shu Q; Jung HL; Chow CW; Perlaky L; Leung HC; Su J; Blaney S; Lau CC
Clin Cancer Res; 2004 Feb; 10(3):1150-9. PubMed ID: 14871995
[TBL] [Abstract][Full Text] [Related]
15. Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line.
Kusaczuk M; Krętowski R; Bartoszewicz M; Cechowska-Pasko M
Tumour Biol; 2016 Jan; 37(1):931-42. PubMed ID: 26260271
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
Zhang AL; Russell PJ; Knittel T; Milross C
Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma.
Shoji M; Ninomiya I; Makino I; Kinoshita J; Nakamura K; Oyama K; Nakagawara H; Fujita H; Tajima H; Takamura H; Kitagawa H; Fushida S; Harada S; Fujimura T; Ohta T
Int J Oncol; 2012 Jun; 40(6):2140-6. PubMed ID: 22469995
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Effects of Arsenite on Radiosensitization of Glioblastoma Cells.
Ninomiya Y; Yu D; Sekine-Suzuki E; Nakajima T
Anticancer Res; 2017 Aug; 37(8):4111-4117. PubMed ID: 28739695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]